Founded by a chronic pain patient
CBD that takes inflammation seriously.
After 23 years with rheumatoid arthritis, I couldn't find a CBD formulation that matched what the research actually supported. So I made one.
Every product page cites the clinical trial. Including the null results.
"I didn't start Reclaim Labs to sell CBD. I started it because this formula gave me my life back."
— Ron Lev, founder
What Reclaim Labs is
A research-led CBD brand for the inflammation cohort — autoimmune, joint, sports recovery (40+), inflammaging, and sleep-stress. The flagship 2800mg broad-spectrum oil is THC-free; the NANO 1000mg roll-on uses nano-emulsion for 3–5× transdermal delivery vs standard topicals; the 50mg patches are isolate-based for drug-test-safe systemic dosing. Every product page cites the peer-reviewed evidence — including the null trials. Founded by Ron Lev after 23 years of rheumatoid arthritis on chronic prednisone.
Three products. One purpose.
Formulated around delivery science — oral bioavailability, nano-emulsion penetration, and transdermal steady-state. Not just CBD in a bottle.
#1 Bestseller Systemic inflammation support
2800mg Broad Spectrum Oil
The flagship formula Ron developed for his own RA protocol. THC-free. Whole-plant cannabinoid profile. One full dropper = 93mg CBD.
Subscribe & Save 15% → $67
Take with food — Birnbaum 2019 shows high-fat meal raises CBD absorption 4–5×
Nano technology Targeted joint & muscle relief
NANO 1000mg Roll-On
Nano-emulsion formula penetrates 3–5× deeper than standard topicals. Cooling gel. Non-greasy. Apply directly to the joint.
Subscribe & Save 15% → $47
Nano-emulsion vs standard topical: Reddy 2023. Topical CBD cannot reach hip or spine joints — use the oil for those.
24hr relief 24-hour slow-release delivery
50mg CBD Patch
Transdermal isolate patch. Bypasses first-pass liver metabolism for steady-state delivery over 24 hours. Zero THC — safe for drug testing.
Subscribe & Save 10% → $16
Oral CBD produces concentration spikes and troughs. Transdermal delivers consistent plasma levels — better for chronic pain management.
Most popular bundle
The Complete Relief System
CBD Oil + Roll-On + Patches — choose your patches pack, save 15% instantly
Save up to $26 — 15% off individual prices
Which formula is right
for your pain?
Answer 8 quick questions about your condition, learn how CBD actually works, and we'll recommend the exact product formulated for your pain type.
What makes Reclaim different
Most CBD brands make claims. We make arguments — and show our work.
Every claim cites the study
Not "studies show CBD helps with inflammation." The specific trial, the PubMed ID, the sample size, the design, and whether it was in humans or rats. Readers can check — and should.
We cite the null results too
Sports-recovery RCTs for CBD are mostly null. The cytokine RCTs are inconsistent. The topical-on-hip evidence doesn't exist. Saying so builds more trust than pretending the signal is clean everywhere.
Founded by a patient, not a marketer
Ron spent 23 years with RA before formulating this. He knows why the drug interactions section matters. He reads the same literature his customers do. The dosing recommendations come from the pharmacology, not the marketing brief.
Why Reclaim exists
Diagnosed at 15.
23 years on prednisone.
Then this.
Rheumatoid arthritis at 15 means you spend most of your adult life managing a disease that most doctors are still figuring out. Chronic prednisone works — until the long-term costs start compounding. Bone density. Metabolic effects. Adrenal suppression.
Ron started reading the CBD pharmacology the way anyone does when they're desperate: slowly, skeptically, and with a calculator. He built a formulation around what the evidence actually supported — high potency, THC-free, bioavailability-optimized. He took it. It gave him enough back that he could have a more honest conversation with his prescriber about tapering.
The research content on this site is written the same way he had to learn it — without falling for marketing language that the controlled trials don't support.
Read Ron's full story →Six areas we write about
We focus on conditions where CBD has meaningful research signal. Where the RCTs are null, we say so.
Autoimmune & inflammation
RA, Hashimoto's, lupus, psoriatic arthritis — where CBD fits in autoimmune protocols.
Joint & musculoskeletal
Knee OA, hip OA, low back, shoulder. The Pramhas 2023 RCT and the topical vs oral question.
Sports recovery (40+)
An honest read for masters athletes: sports-recovery RCTs are mostly null. Where CBD does have signal.
Inflammaging (35+)
Chronic low-grade inflammation as the body ages. The Franceschi 2018 framework.
Sleep & stress
Sleep continuity, cortisol regulation. Shannon 2019 sleep signal and Bergamaschi 2011 anxiety anchor.
CBD science & dosing
How CBD works, bioavailability by delivery route, the inverted-U dose curve, and how to titrate.
Start here
Evidence-anchored explainers from the Reclaim Labs research desk. Every article cites primary literature.
Chronic pain
CBD and chronic pain: what the evidence actually shows across pain types
Nociceptive, neuropathic, nociplastic — the evidence varies sharply by pain type. Null results included.
Read →Drug interactions
CBD drug interactions: CYP450, warfarin, SSRIs, and what to ask your prescriber
CBD inhibits the same enzymes that clear most prescription medications. Per-drug evidence and severity ratings.
Read →Joint pain
CBD and knee osteoarthritis: Pramhas 2023 RCT and what the human data actually shows
The strongest joint-pain RCT for CBD in humans. The topical vs oral question answered honestly.
Read →Anxiety & sleep
CBD and anxiety: Bergamaschi 2011 RCT, Shannon 2019, and what the evidence shows
The 5-HT1A mechanism, the dose-response curve, and why CBD is not a benzodiazepine.
Read →